Endovascular Treatments for Pulmonary Embolism: A Narrative Historical Review
- 26 July 2026
- journal article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
Abstract
Introduction: This narrative review examines endovascular treatments for acute pulmonary embolism (PE), focusing on percutaneous mechanical thrombectomy (MT). Methods: PubMed (Medline) and Google Scholar were searched from January 1990 up to November 2024 (updated Feb 2026). Studies were included if they discussed PE and the use of thrombectomy devices. Full‐text randomised controlled trial studies, observational studies, case series, and case reports were included. Opinion articles, letters to the editor, animal studies, and non‐English studies were excluded. Results: A total of 116 articles were reviewed. Current guidelines recommend systemic thrombolysis as first‐line reperfusion for high‐risk PE, whereas intermediate‐high‐risk PE is managed with anticoagulation and monitoring, with reperfusion reserved for deterioration. MT is currently an alternative, mainly when thrombolysis is contraindicated or has failed. However, the last two decades have seen a surge in thrombectomy devices including the FlowTriever, Indigo, and AngioVac. Numerous studies, most notably the PEERLESS trial, have reported rapid haemodynamic improvement with MT, including reduced pulmonary artery pressure, low major bleeding rates, and fewer intensive care admissions [1]. Conclusion: MT has shown early promise in the management of PE. Much of the current evidence derives from single‐arm trials, registries, and industry‐sponsored observational studies, with randomised comparative data still limited. Nonetheless, randomised evidence suggests MT may reduce clinical deterioration, intensive care use, and hospital length of stay compared with catheter‐directed thrombolysis, though without a demonstrated difference in mortality, intracranial haemorrhage, or major bleeding. Further trial evidence is required before MT is recommended as first‐line in PE.Keywords
This publication has 55 references indexed in Scilit:
- Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolismAmerican Heart Journal, 2024
- A meta-analysis of outcomes of aspiration thrombectomy for high and intermediate-risk pulmonary embolismCurrent Problems in Cardiology, 2024
- Catheter-directed thrombolysis versus thrombectomy for submassive and massive pulmonary embolism: A systematic review and meta-analysisCardiovascular Revascularization Medicine, 2023
- Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: A multicenter experienceCatheterization and Cardiovascular Interventions, 2022
- Percutaneous thrombectomy in patients with massive and very high‐risk submassive acute pulmonary embolismCatheterization and Cardiovascular Interventions, 2020
- Meta-Analysis of Catheter Directed Ultrasound-Assisted Thrombolysis in Pulmonary EmbolismThe American Journal of Cardiology, 2019
- Simplification of the Pulmonary Embolism Severity Index for Prognostication in Patients With Acute Symptomatic Pulmonary EmbolismArchives of internal medicine (1960), 2010
- A History of Pulmonary Embolism and Deep Venous ThrombosisCritical Care Clinics, 2009
- Rheolytic thrombectomy in patients with massive and submassive acute pulmonary embolismCatheterization and Cardiovascular Interventions, 2008
- Friedrich Trendelenburg and the Surgical Approach to Massive Pulmonary EmbolismArchives of Surgery, 1990